Helix BioPharma (TSE:HBP) Stock Price Passes Above 50-Day Moving Average of $0.22

Helix BioPharma Corp. (TSE:HBP)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.22 and traded as high as C$0.24. Helix BioPharma shares last traded at C$0.24, with a volume of 7,000 shares changing hands.

Helix BioPharma Stock Performance

The firm has a market capitalization of C$53.92 million, a price-to-earnings ratio of -7.83 and a beta of -0.78. The company has a current ratio of 1.46, a quick ratio of 1.04 and a debt-to-equity ratio of 773.67. The company has a fifty day moving average price of C$0.22 and a 200-day moving average price of C$0.20.

Helix BioPharma Company Profile

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging.